Automated and fast analysis of PET brain studies to quantify subregional tracer binding in native patient brain space

Research advancements require advanced technology. PETQuant is a research-specific component of NeuroQuant® that provides physicians with a cutting-edge tool in the study of frontotemporal dementia and Alzheimer’s disease. PETQuant automatically quantifies PET tracer bindings localized to brain structures identified by NeuroQuant 3D T1 MRI segmentation. Users can select between two tracers for metabolic (FDG) and amyloid-based (Florbetapir) analysis. Visual and statistical (Z-score) comparisons of each normalized regional PET tracer value can be compared to normative population data. Compatible with GE, Philips, and Siemens PET and PET/CT scanners, PETQuant enables better insight that leads to breakthrough discoveries.

Amyloid Deposition and Metabolism Analysis

Option available to license two separate reports that correspond to the PET tracer used.

Easy-to-Read Reports

Color-coded graphical presentation simplifies quantitative reads.

24/7 Access

CorTechs Labs’ secure, cloud-based system provides access anytime, from virtually anywhere.

Export Raw Rata

Data is easily exported to a CSV file for your research needs.

Obtain a Detailed Look

A color-blended brain segmentation overlay of the 3D MR series enables closer inspection on a PACS or other DICOM.


A breakthrough solution for researchers

PETQuant is currently available for research use only. This leading-edge automation software provides research physicians and clinicians with fast, accurate quantification of subregional tracer binding in the quest to unlock new treatments for dementia and Alzheimer’s disease.